334 related articles for article (PubMed ID: 32165289)
1. CCR5 genotype and pre-treatment CD4+ T-cell count influence immunological recovery of HIV-positive patients during antiretroviral therapy.
Carvalho-Silva WHV; Andrade-Santos JL; Guedes MCDS; Crovella S; Guimarães RL
Gene; 2020 May; 741():144568. PubMed ID: 32165289
[TBL] [Abstract][Full Text] [Related]
2. Better CD4+ T cell recovery in Brazilian HIV-infected individuals under HAART due to cumulative carriage of SDF-1-3'A, CCR2-V64I, CCR5-D32 and CCR5-promoter 59029A/G polymorphisms.
Rigato PO; Hong MA; Casseb J; Ueda M; de Castro I; Benard G; Duarte AJ
Curr HIV Res; 2008 Sep; 6(5):466-73. PubMed ID: 18855658
[TBL] [Abstract][Full Text] [Related]
3. [Effect of CCR5delta32, CCR5m303, CCR2-64I and SDF1-3'A gene polymorphism on the prognosis of Chinese HIV-1 carriers].
Wang XH; Feng TJ; Wang FS; Chen L; Shi XD; Jin L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):256-9. PubMed ID: 16261210
[TBL] [Abstract][Full Text] [Related]
4. Distribution of CCR5-Delta32, CCR5 promoter 59029 A/G, CCR2-64I and SDF1-3'A genetic polymorphisms in HIV-1 infected and uninfected patients in the west region of Cameroon.
Nkenfou CN; Mekue LC; Nana CT; Kuiate JR
BMC Res Notes; 2013 Jul; 6():288. PubMed ID: 23880174
[TBL] [Abstract][Full Text] [Related]
5. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K
J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189
[TBL] [Abstract][Full Text] [Related]
6. Analysis of CCR5, CCR2, CX3CR1, and SDF1 polymorphisms in HIV-positive treated patients: impact on response to HAART and on peripheral T lymphocyte counts.
Puissant B; Roubinet F; Massip P; Sandres-Saune K; Apoil PA; Abbal M; Pasquier C; Izopet J; Blancher A
AIDS Res Hum Retroviruses; 2006 Feb; 22(2):153-62. PubMed ID: 16478397
[TBL] [Abstract][Full Text] [Related]
7. IL18 gene polymorphism and its influence on CD4+ T-cell recovery in HIV-positive patients receiving antiretroviral therapy.
Andrade-Santos JL; Carvalho-Silva WHV; Coelho AVC; Souto FO; Crovella S; Brandão LAC; Guimarães RL
Infect Genet Evol; 2019 Nov; 75():103997. PubMed ID: 31401307
[TBL] [Abstract][Full Text] [Related]
8. CCR5∆32 and SDF1 3'A: Gene Variants, Expression and Influence on Biological Markers for the Clinical Progression to AIDS among HIV-1 Virus Controllers in a Mixed Population of the Amazon Region of Brazil.
Lima ÉRG; Queiroz MAF; Lima SS; Machado LFA; Cayres-Vallinoto IMV; Vallinoto ACR; Figueiredo FAPL; Guerreiro JF; Guimarães Ishak MO; Ishak R
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902388
[TBL] [Abstract][Full Text] [Related]
9. CCR5Delta32 and promoter polymorphisms are not correlated with initial virological or immunological treatment response.
Brumme ZL; Chan KJ; Dong W; Hogg R; O'Shaughnessy MV; Montaner JS; Harrigan PR
AIDS; 2001 Nov; 15(17):2259-66. PubMed ID: 11698699
[TBL] [Abstract][Full Text] [Related]
10. Stromal cell-derived factor (SDF) 1-3'A polymorphism may play a role in resistance to HIV-1 infection in seronegative high-risk Thais.
Tiensiwakul P
Intervirology; 2004; 47(2):87-92. PubMed ID: 15192272
[TBL] [Abstract][Full Text] [Related]
11. [Distribution of HIV resistance CCR5-delta 32, CCR2-64 I and SDF1-3'A alleles and their polymorphisms in the Han population in China].
Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Shi M; Jiang J; Wang Y; Zhang B; Liu M; Li Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):256-60. PubMed ID: 11860793
[TBL] [Abstract][Full Text] [Related]
12. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
13. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
[TBL] [Abstract][Full Text] [Related]
14. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.
Bogner JR; Lutz B; Klein HG; Pollerer C; Troendle U; Goebel FD
HIV Med; 2004 Jul; 5(4):264-72. PubMed ID: 15236615
[TBL] [Abstract][Full Text] [Related]
15. [Variant genotyping of CCR2-64I, SDF1-3' A and CCR5Delta32 in HIV-1 infected Chinese long-term nonprogressors].
Wang SX; Shang H; Han XX; Zhang ZN; Wang YN; Zhang M; Jiang YJ; Liu J; Su YL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):16-9. PubMed ID: 16642210
[TBL] [Abstract][Full Text] [Related]
16. Stromal Cell-Derived Factor-1-3'A Polymorphism Favors HIV-1 Infection in Mexican Women.
Velarde-Félix JS; Cázarez-Salazar SG; Díaz-Camacho SP; Osuna-Ramírez I; Ochoa-Ramírez LA; Sánchez-Zazueta JG; Ramírez M
Intervirology; 2015; 58(6):357-62. PubMed ID: 26859597
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of CCR5 delta 32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infection.
Sei S; Boler AM; Nguyen GT; Stewart SK; Yang QE; Edgerly M; Wood LV; Brouwers P; Venzon DJ
AIDS; 2001 Jul; 15(11):1343-52. PubMed ID: 11504955
[TBL] [Abstract][Full Text] [Related]
18. Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil.
Gomes STM; Gomes ÉR; Dos Santos MB; Lima SS; Queiroz MAF; Machado LFA; Cayres-Vallinoto IMV; Vallinoto ACR; de O Guimarães Ishak M; Ishak R
BMC Infect Dis; 2017 Jun; 17(1):381. PubMed ID: 28571570
[TBL] [Abstract][Full Text] [Related]
19. Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.
Tan XH; Zhang JY; Di CH; Hu AR; Yang L; Qu S; Zhao RL; Yang PR; Guo SX
Infect Genet Evol; 2010 Mar; 10(2):268-72. PubMed ID: 19958843
[TBL] [Abstract][Full Text] [Related]
20. The Consequence of a Founder Effect: CCR5-∆32, CCR2-64I and SDF1-3'A Polymorphism in Vlach Gypsy Population in Hungary.
Juhász E; Béres J; Kanizsai S; Nagy K
Pathol Oncol Res; 2012 Apr; 18(2):177-82. PubMed ID: 21667221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
